SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VINCENZI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.155
AS - Asia 8.722
EU - Europa 4.950
SA - Sud America 1.548
AF - Africa 222
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 30.621
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.818
SG - Singapore 3.285
CN - Cina 2.136
BR - Brasile 1.213
IT - Italia 1.137
VN - Vietnam 1.092
DE - Germania 815
HK - Hong Kong 681
UA - Ucraina 547
GB - Regno Unito 472
TR - Turchia 437
PL - Polonia 435
FI - Finlandia 380
FR - Francia 312
JP - Giappone 229
SE - Svezia 213
RU - Federazione Russa 205
IN - India 201
CA - Canada 180
ID - Indonesia 150
AR - Argentina 118
MX - Messico 115
BD - Bangladesh 106
NL - Olanda 91
ZA - Sudafrica 88
IQ - Iraq 62
ES - Italia 56
BE - Belgio 50
CO - Colombia 50
EC - Ecuador 49
AT - Austria 48
PK - Pakistan 44
UZ - Uzbekistan 41
LT - Lituania 39
VE - Venezuela 38
MY - Malesia 32
CZ - Repubblica Ceca 31
SA - Arabia Saudita 30
MA - Marocco 27
KE - Kenya 26
AE - Emirati Arabi Uniti 25
CL - Cile 25
TN - Tunisia 24
CH - Svizzera 23
PH - Filippine 22
PY - Paraguay 20
EG - Egitto 16
JO - Giordania 16
IE - Irlanda 15
IL - Israele 15
KR - Corea 15
BO - Bolivia 13
AU - Australia 12
DZ - Algeria 12
NP - Nepal 12
PE - Perù 11
ET - Etiopia 10
PT - Portogallo 10
TW - Taiwan 10
UY - Uruguay 10
EU - Europa 8
IR - Iran 8
KZ - Kazakistan 8
BG - Bulgaria 7
CR - Costa Rica 7
HN - Honduras 7
KG - Kirghizistan 7
LV - Lettonia 7
PS - Palestinian Territory 7
TH - Thailandia 7
AL - Albania 6
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
HU - Ungheria 6
JM - Giamaica 6
RO - Romania 6
RS - Serbia 6
PA - Panama 5
SY - Repubblica araba siriana 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CG - Congo 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HR - Croazia 4
LB - Libano 4
NO - Norvegia 4
OM - Oman 4
AM - Armenia 3
CY - Cipro 3
GE - Georgia 3
KW - Kuwait 3
MK - Macedonia 3
NI - Nicaragua 3
PR - Porto Rico 3
AO - Angola 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
DK - Danimarca 2
Totale 30.589
Salva come PNG Salva come JPEG
Città #
Singapore 2.087
Ashburn 1.966
Fairfield 1.187
Woodbridge 1.155
San Jose 924
Chandler 795
Beijing 758
Houston 737
Ann Arbor 709
Hong Kong 662
Santa Clara 649
Jacksonville 617
Seattle 499
Wilmington 470
Cambridge 421
Warsaw 419
Ferrara 364
Ho Chi Minh City 344
Los Angeles 321
Hanoi 266
Dallas 263
Munich 248
Izmir 236
Tokyo 216
Council Bluffs 206
New York 199
Nanjing 169
Helsinki 167
Princeton 163
Lauterbourg 162
Shanghai 136
Milan 132
São Paulo 123
Boardman 119
Jakarta 117
San Diego 108
Orem 105
Turku 90
London 81
Buffalo 78
The Dalles 70
Chennai 68
Chicago 68
Frankfurt am Main 66
Mexico City 63
Montreal 59
Tianjin 59
Da Nang 58
Bremen 57
Bologna 56
Toronto 55
Denver 53
Nanchang 53
Johannesburg 51
Shenyang 49
Brooklyn 48
Brussels 47
Dearborn 47
Stockholm 45
Hefei 43
Haiphong 41
Manchester 41
San Francisco 40
Boston 37
Moscow 37
Atlanta 36
Hebei 36
Nuremberg 36
Phoenix 36
Tashkent 36
Jiaxing 35
Falls Church 34
Falkenstein 33
Poplar 33
Amsterdam 32
Changsha 31
Rio de Janeiro 31
Belo Horizonte 28
Columbus 28
Rome 26
Ankara 25
Auburn Hills 24
Zhengzhou 24
Brno 23
Norwalk 23
Washington 23
Curitiba 22
Dong Ket 22
Baghdad 21
Biên Hòa 21
Guangzhou 21
Mountain View 21
Porto Alegre 21
Des Moines 19
Zurich 19
Augusta 18
Brasília 18
Hải Dương 18
Medellín 18
Jinan 17
Totale 20.688
Salva come PNG Salva come JPEG
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 402
Pharmacology of Adenosine Receptors: The State of the Art 381
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 285
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 283
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 279
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 278
The A3 adenosine receptor: history and perspectives 275
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 272
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 272
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 270
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 264
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 261
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 259
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 257
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 257
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 255
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 255
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 251
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 251
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 249
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 248
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 245
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 239
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 239
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 234
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 226
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 224
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 219
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 217
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 216
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 215
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 213
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 213
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 211
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 209
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 208
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 208
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 205
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 204
Pathological overproduction: the bad side of adenosine 204
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 201
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 200
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 199
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 196
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 196
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 196
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 196
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 195
Targeting A3 and A2A adenosine receptors in the fight against cancer 195
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 194
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 192
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 191
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 189
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 188
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 187
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 186
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 186
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 186
Development of novel pyridazinone-based adenosine receptor ligands 181
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 179
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 175
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 175
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 174
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 174
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 173
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E2 and cytokine production in human osteoarthritic synovial fibroblasts 170
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 170
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 169
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 169
Effects of pulsed electromagnetic field exposure on adenosine receptors in human fibroblast-like synoviocytes. 168
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 167
The role of adenosine receptors in rheumatoid arthritis. 166
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 165
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 165
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 164
A2A adenosine receptors and chronic caffeine intake in human neutrophils 163
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 162
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 162
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 162
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 161
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition (dagger). 160
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 160
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 159
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 157
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 157
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 155
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 155
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 154
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 154
Effect of Pulsed Electromagnetic Field Exposure on Adenosine Receptors in Human Fibroblast-like Synoviocytes 153
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 153
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases 153
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 152
L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter 149
Adenosine and inflammation: Here, there and everywhere 148
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 147
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. 147
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice 147
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 146
Totale 20.262
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.266
Totale 132.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021847 0 0 0 0 0 0 0 0 0 423 289 135
2021/20221.497 46 155 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20255.044 109 151 374 288 469 510 241 284 803 515 695 605
2025/202612.448 1.329 544 1.110 1.570 2.017 926 1.558 773 1.273 1.348 0 0
Totale 31.037